Stereotaxis (STXS) Announces First Robotic MAGiC Sweep Catheter Procedure at Deborah Heart and Lung Center

Stereotaxis, Inc. (NYSE:STXS) is one of the 15 Best Robotics Stocks to Buy Under $20.

Deborah Heart and Lung Center in New Jersey Successfully Completes First Robotic High-Density Mapping Procedure With STXS’ MAGiC Sweep Catheter, Stereotaxis, Inc. (STXS) Announces

On September 2, 2025, Stereotaxis, Inc. (NYSE:STXS) announced that the Deborah Heart and Lung Center in New Jersey had successfully completed the first robotic high-density mapping procedure in the U.S. with its MAGiC Sweep™ catheter. This catheter, the first and only robotically steered high-density electrophysiology mapping catheter, provides more precise and comprehensive maps of cardiac architecture for improved arrhythmia diagnosis and treatment. The rollout follows recent FDA clearance, with a European regulatory review also underway.

Stereotaxis, Inc. (NYSE:STXS) is a global leader in surgical robotics for minimally invasive endovascular procedures. Its robotic systems, tools, and information platforms enable safer, more accurate treatments. Over 150,000 patients worldwide have benefited from its technology. It is one of the best robotic stocks.

While we acknowledge the potential of STXS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than STXS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Benefit From AI and 12 Best Quantum Computing Stocks to Buy According to Wall Street Analysts.

Disclosure: None.